Journal
ADDICTION BIOLOGY
Volume 16, Issue 1, Pages 142-144Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1369-1600.2010.00274.x
Keywords
CYP2B6; fatalities; metabolism; methadone; OPRM1; pharmacogenomics
Categories
Funding
- University scholarship for PhD research
Ask authors/readers for more resources
The largest proportion of methadone-associated deaths occurs during the drug induction phase. We analysed methadone-related fatalities for gene variations linked with methadone action. A significant association between high methadone concentrations and the CYP2B6*6 allele characteristic of the slow metabolizer phenotype was identified. We suggest that the risk of methadone fatality may be predetermined in part by the CYP2B6*6 allele. A significant correlation was also observed between post-mortem benzodiazepine concentrations and the OPRM1 A118G allele GA in methadone-related fatalities. Screening for these susceptibility variations prior to methadone prescription could assist in reducing the potential for serious adverse effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available